…
The Global Prostate Health Market Size was Valued at USD 32.6 Billion in 2023 and the Worldwide Prostate Health Market…
Naoki Okamura, CEO of Astellas Pharma, discusses his business strategy for the company and the outlook for Japans economic growth…
Dublin, May 21, 2024 (GLOBE NEWSWIRE) -- The "Antiandrogens Market Report: Trends, Forecast and Competitive Analysis to 2030"…
The surge in liver disease therapeutics demand stems mainly from a growing population afflicted with liver ailments, elevated alcohol intake,…
Earnings call: Astellas Pharma exceeds revenue forecast, faces profit dip…
…
The vasomotor symptoms market is expected to experience substantial growth in the upcoming years, driven by the introduction of new…
…
…
The Global Transplantation Market Size was valued at USD 8.5 Billion in 2022 and the Worldwide Transplantation Market Size is…
International equities yield more and cost less on average than U.S. stocks. Legrand, RELX, and Astellas Pharma are among the…
Seagen (SGEN) and Astellas Pharma announce that the FDA has accepted the label expansion-seeking application for the Padcev/Keytruda combo under…
[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global…
…
…
Im Plus liegt gegenwärtig der Anteilsschein von Astellas Pharma . Der jüngste Kurs betrug 12,33 Euro. Am Aktienmarkt hat sich…
München (ots) - - Astellas Pharma initiiert repräsentative Umfrage mit über 1.000 Frauen in Deutschland zwischen 40 und 65 Jahren…
[230+ Pages Report] According to a market research study published by The Brainy Insights, the demand analysis of Global…
Major mucous membrane decontamination market players include Astellas Pharma Inc., Bausch Health Companies Inc., Genentech, Inc., Lipidor AB., Pfizer Inc.,…
Apellis Pharmaceuticals Inc. shares APLS jumped 8% premarket on Tuesday after competitor Iveric Bio, a unit of Astellas Pharma Inc.…
…
BASEL (dpa-AFX) - Sandoz a unit of biopharmaceutical major Novartis AG (NVS) said on Monday that it has completed acquiring…
Basel, August 28, 2023 – Sandoz, a global leader in generic and biosimilar medicines, has successfully completed the acquisition of…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Poseida Therapeutics Shares Leap on Astellas Investments >PSTX...…
Poseida Therapeutics in $50 Million Investment Deal With Astellas >PSTX...…
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…
Co-led by Santé Ventures and Longwood, the financing round has seen participation from Alexandria Venture Investments, Astellas Venture Management, and…
Beijing, July 21 (Jiji Press)--The Japanese Embassy in Beijing made its first consular visit in person to a Japanese man…
The Japanese Embassy in Beijing has been granted in-person consular access to an employee of pharmaceutical firm Astellas Pharma Inc.,…
In April this year, Astellas Pharmas subsidiary agreed to buy 100% of the outstanding shares of Iveric Bio for $40 per share in…
TOKYO and PARSIPPANY, N.J. , July 11, 2023 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura,…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
TOKYO (dpa-AFX) - Astellas Pharma Inc. (ALPMY, ALPMY) announced positive results from the Phase 3b DAYLIGHT clinical trial for fezolinetant,…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
BEIJING (dpa-AFX) - Biopharmaceutical companies Astellas Pharma Inc. (ALPMY) and Cullgen Inc, announced on Thursday a research collaboration and exclusive…
TOKYO (dpa-AFX) - Astellas Pharma Inc. (ALPMY) announced Friday the submission of a New Drug Application or NDA to Japans…
WASHINGTON (dpa-AFX) - Astellas Pharma Inc. (ALPMY) and Kate Therapeutics, announced on Thursday that they have entered an exclusive license…
...June 8 (Reuters) -
* KATE THERAPEUTICS - DEBUTS $51 MILLION SERIES......…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Detroit, May 26 (Jiji Press)--Japanese trade minister Yasutoshi Nishimura sought the early release of a male employee of Japanese drugmaker…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…
Conduct collaborative research on Sonys unique polymeric materials to achieve high-DAR ADC TOKYO, May 16, 2023 /PRNewswire/ -- Sony Corporation…
TOKYO (dpa-AFX) - Sony Corp. (SON.L, SNE) and Astellas Pharma Inc. (ALPMY, ALPMY) have entered into a research agreement to…